Clinical Trial Update: Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Cytochlor and tetrahydrouridine as radiosensitizers with cisplatin plus radiation in patients with advanced squamous cell carcinoma of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Oral Cavity
• Squamous Cell Carcinoma of the Oropharynx

Drugs mentioned

• CISPLATIN (cisplatin)
• Cytochlor (chlorambucil)
• Tetrahydrouridine (tetrahydrouridine)

Snippet

Sponsor: University of Miami | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED